Front Endocrinol (Lausanne)
May 2024
The incidence of concomitant thyroid cancer in Graves' disease varies and Graves' disease can make the diagnosis and management of thyroid nodules more challenging. Since the majority of Graves' disease patients primarily received non-surgical treatment, identifying biomarkers for concomitant thyroid cancer in patients with Graves' disease may facilitate planning the surgery. The aim of this study is to identify the biomarkers for concurrent thyroid cancer in Graves' disease patients and evaluate the impact of being overweight on cancer risk.
View Article and Find Full Text PDFBRAF positivity is associated with increased aggressiveness of papillary thyroid cancer (PTC), and age is an important prognostic factor. However, the association between age and BRAF positivity and the recurrence risk has not been investigated. This study aimed to investigate the impact of age on recurrence between patients with BRAF-positive and -negative PTC.
View Article and Find Full Text PDF